Abstracts tagged "arthritis and biomarkers"

Abstract Number: 1526 • 2016 ACR/ARHP Annual Meeting
Serum y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis
Melissa Ramirez-Villafaña¹, Paulina Hernandez-Cuervo², Ana Miriam Saldaña-Cruz³, Edsaul Emilio Perez-Guerrero^4,5, Nicte Selene Fajardo-Robledo⁶, Edy David Rubio-Arellano⁷, Alejandra Flores-Chavez⁸, Javier Alejandro Aceves-Aceves^9,10, Arnulfo Hernan Nava-Zavala¹¹, Mario Salazar-Paramo¹², Miguel Huerta¹³, Miriam Fabiola Alcaraz-Lopez¹⁴, Jorge Ivan Gamez-Nava¹⁵ and Laura Gonzalez-Lopez¹⁶, ¹Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 110, Jalisco, Mexico, ²Programa de Doctorado en Ciencias de la Salud Pública, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara. Guadalajara, Jalisco, México., Guadalajara, Mexico, ³Centro Universitario de Investigación Biomédica. Universidad de Colima, Colima, Mexico, ⁴Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, ⁵Doctorado en Farmacología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, ⁶Laboratorio de Investigación y Desarrollo Farmacéutico, Universidad de Guadalajara, Centro Universitario de Ciencias Exactas e Ingenierias, Jalisco, Mexico, ⁷Centro Universitario de Investigación Biomédica. Universidad de Colima., Colima, Colima, Mexico, ⁸Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, ⁹Departamento de Medicina Interna-Reumatologia, Hospital General Regional 110, IMSS, Guadalajara, Jalisco, Mexico, ¹⁰Posgrado de Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara., Guadalajara, Jalisco, Mexico, ¹¹Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Jalisco, Mexico, ¹²Physiology, HSC, University of Guadalajara, Guadalajara, Mexico, ¹³Centro Universitario de Investigación Biomédica, Universidad de Colima, Colima, Mexico, ¹⁴Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 45, Jalisco, Mexico, ¹⁵Rheumatology, Centro Medico de Occidente, Guadalajara Jal, Mexico, ¹⁶Departamento de Medicina Interna/Rheumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico
Background/Purpose: Overweight and obesity are comorbidities that may increase the risk of cardiovascular disease in rheumatoid arthritis. Increase in in body fat is observed in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].